Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BBOX1 | O75936 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 6/20 | 0.33 |
| ▸ | CNR1 | P21554 | 4/20 | 0.33 |
| ▸ | CA4 | P22748 | 2/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | PPARD | Q03181 | 1/20 | 0.33 |
| ▸ | PPARA | Q07869 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sorbic Acid SCHEMBL1766257 | 1.00 | BBOX1 (0.36) | BBOX1ALDH1A1CNR2CNR1CA4 | |
| Sorbic Acid SCHEMBL11578741 | 0.97 | BBOX1 (0.37) | BBOX1ALDH1A1CNR2CNR1CA4 | |
| Sorbic Acid SCHEMBL562945 | 0.97 | BBOX1 (0.37) | BBOX1ALDH1A1CNR2CNR1CA4 | |
| Sorbic Acid SCHEMBL11578745 | 0.97 | BBOX1 (0.37) | BBOX1ALDH1A1CNR2CNR1CA4 | |
| Sorbic Acid SCHEMBL2485339 | 0.94 | BBOX1 (0.36) | BBOX1ALDH1A1CNR2CNR1CA4 | |
| Sorbic Acid SCHEMBL11681562 | 0.94 | BBOX1 (0.36) | BBOX1ALDH1A1CNR2CNR1CA4 | |
| Sorbic Acid SCHEMBL221488 | 0.94 | — | — | |
| Sorbic Acid SCHEMBL561901 | 0.94 | BBOX1 (0.36) | BBOX1ALDH1A1CNR2CNR1CA4 | |
| Sorbic Acid SCHEMBL562652 | 0.94 | BBOX1 (0.36) | BBOX1ALDH1A1CNR2CNR1CA4 | |
| Sorbic Acid SCHEMBL146360 | 0.94 | BBOX1 (0.36) | BBOX1ALDH1A1CNR2CNR1CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024258867-A1 | SYSTEM AND METHOD FOR PRESERVING ALGAE | Macro Oceans Inc. (US) | 2024-12-19 | — | — | WO | disclosed |
| US-20240409878-A1 | SYSTEM AND METHOD FOR PRESERVING ALGAE | Macro Oceans Inc. (US) | 2024-12-12 | — | — | US | disclosed |
| CN-113755588-A | Genetic polymorphism detection kit for fluorouracil adverse reaction and curative effect prediction, detection method and application thereof | 菲思特(上海)生物科技有限公司 | 2021-12-07 | — | — | CN | disclosed |
| EP-2317977-B1 | PHARMACEUTICAL COMPOSITION HAVING RELATIVELY LOW IONIC STRENGTH | ALCON RES LTD (US) | 2014-07-23 | — | — | EP | disclosed |
| EP-2317977-A2 | PHARMACEUTICAL COMPOSITION HAVING RELATIVELY LOW IONIC STRENGTH | Alcon Research, Ltd. (US) | 2011-05-11 | — | — | EP | disclosed |
| WO-2010027907-A2 | PHARMACEUTICAL COMPOSITION HAVING RELATIVELY LOW IONIC STRENGTH | ALCON RESEARCH, LTD. (US) | 2010-03-11 | — | — | WO | disclosed |
| US-20100056537-A1 | PHARMACEUTICAL COMPOSITION HAVING RELATIVELY LOW IONIC STRENGTH | ALCON RESEARCH, LTD. | 2010-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100056537-A1 | PHARMACEUTICAL COMPOSITION HAVING RELATIVELY LOW IONIC STRENGTH | KCNN3, KCNJ11, KCNJ1 | BBOX1 4626/4885ALDH1A1 4661/4885CNR2 4302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.